Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

CAPR

Capricor Therapeutics Inc. (NASDAQ:CAPR) Stock Rockets 53% On Heavy Volume: How To Trade Now?

If you are currently on the lookout for biotech stocks to follow, then Capricor Therapeutics Inc. (NASDAQ:CAPR) could be the one to add to your watch list. Yesterday the stock was in sharp focus and ended up with gains of as much as 53% amidst heavy trading. Capricor Therapeutics Announces Intent to File Biologics License …

Continue reading “Capricor Therapeutics Inc. (NASDAQ:CAPR) Stock Rockets 53% On Heavy Volume: How To Trade Now?”

Capricor Therapeutics (NASDAQ:CAPR) Stock Bounces Back After The Fall: What Next?

The biotech firm Capricor Therapeutics (NASDAQ:CAPR) was on the radars of many investors yesterday and the company’s stock ended the day with gains of 5.5%. The gains made by the Capricor stock were reasonable but it is also true that there has been no new development about the company in recent weeks. In this situation, …

Continue reading “Capricor Therapeutics (NASDAQ:CAPR) Stock Bounces Back After The Fall: What Next?”

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.